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RESUMO 
O objetivo do presente trabalho foi avaliar histometricamente o efeito do plasma 
rico em plaquetas (PRP), do vidro bioativo (Perioglas®) e sua associação sobre a 
regeneração periodontal em defeitos intra-ósseos de 3 paredes, além de sua 
combinação à regeneração tecidual guiada (RTG) em defeitos de furca grau II em 
cães. Foram incluídos 9 cães, fêmeas, de raça indefinida e pesando 
aproximadamente 15Kg. Os animais tiveram os segundos e quartos pré-molares e 
segundos molares mandibulares extraídos. Decorridas 12 semanas das extrações, 
foram criados cirurgicamente 4 defeitos intra-ósseos de 3 paredes (dimensões 
4x4x4mm), sendo 2 nas faces mesiais e 2 nas faces distais dos primeiros molares 
mandibulares. Outros 2 defeitos do tipo furca grau II (5x2mm) foram criados na 
face vestibular dos terceiros pré-molares mandibulares. Em todos os defeitos 
foram utilizados dispositivos para cronificação durante 4 semanas. Uma semana 
após a remoção dos dispositivos de cronificação, os animais foram então 
submetidos à cirurgia para tratamento dos defeitos. O lado que recebeu os 
tratamentos com o PRP foi inicialmente sorteado, sendo então designados 
aleatoriamente os respectivos tratamentos: Controle (C); Vidro Bioativo (VB); 
Plasma Rico em Plaquetas (PRP) e PRP+VB, para os defeitos intra-ósseos. O 
lado que recebeu os tratamentos PRP e VB+PRP teve o defeito de furca grau II 
tratado com a associação do PRP+VB+RTG, sendo o dente contra lateral tratado 
com VB+RTG. Decorridas 12 semanas das cirurgias de tratamento, os animais 
foram sacrificados. Após processamento histológico, procedeu-se com a avaliação 
histométrica. Não foram observadas diferenças significantes para os parâmetros 
avaliados nos defeitos intra-ósseos. A extensão de epitélio foi 2,24±0,58 mm, 
1,94±0,37 mm, 1,97±0,37 mm e 1,81±0,61 mm para, Controle, VB, PRP e PRP + 
VB, respectivamente. A adaptação conjuntiva sem formação de cemento foi 
0,90±0,28 mm, 0,84±0,41 mm, 1,07±0,27 mm e 1,15±0,32 mm, respectivamente. 
A extensão de novo cemento foi 2,63±0,70 mm, 2,56±0,36 mm, 2,37±0,38 mm e 
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3,10±0,47 mm, respectivamente. A extensão de novo osso foi 4,77±0,44 mm, 
4,64±0,68 mm, 4,67±0,46 mm e 4,84±0,42 mm, respectivamente. A porcentagem 
de preenchimento do defeito foi 47% no grupo C, 50% com VB, 53% com PRP e 
50% com VB+PRP. Para os defeitos de furca verificou-se diferença significante na 
formação de novo cemento em favor do grupo VB+PRP+RTG (p=0,035). Dento 
dos limites deste estudo pode-se concluir que o uso do VB e PRP de forma 
isolada ou associada não promoveram efeito adicional à regeneração periodontal 
em defeitos intra-ósseos de três paredes em cães. Entretanto, pode-se concluir 
também que o uso do PRP promoveu uma maior formação de cemento em 
defeitos de furca grau II em cães, quando associado ao VB e à RTG. 
 
Palavras-chave: doença periodontal; vidro bioativo; plasma rico em plaquetas; 
regeneração periodontal; defeitos periodontais; defeito intra-
ósseo; defeito de furca grau II. 
 
 
xi
ABSTRACT 
The objective of the present study was to evaluate at the histological level the 
effect of platelet-rich plasma (PRP), bioactive glass (BG) and his association on 
periodontal regeneration of 3-wall intrabony defects and its combination with 
guided tissue regeneration (GTR) on the regeneration of class II lesions in dogs.  
Nine mongrel dogs with approximately 15Kg were used in the experiment. The 
animals had the second premolar, fourth premolar and second molar at the 
mandible extracted. After twelve weeks, three-wall intra-bony defects (4x4x4m) 
were surgically created at the mesial and distal aspect of first mandibular molar. 
Class II furcation lesions (5x2mm) were surgically created, bilaterally, at the buccal 
aspect of mandibular third premolar. All defects were exposed to plaque 
accumulation for 1 month. One week after to remove the cronification devices, the 
defects were submitted to treatments.  All treatments with PRP were located at the 
same side. Intrabony and class II furcation defects were randomly assigned to:  
Control (C); BG; PRP and PRP+BG, and PRP+BG+GTR and BG+GTR, 
respectively.  Dogs were sacrificed 90 days after the surgeries and the blocks 
containing the experimental specimens were processed for histological analysis. 
No statistically significant differences were observed in all parameters for the 
treatment of intrabony defects. The extension of total epithelium (sulcular and 
junctional epithelium) was 2.24 ± 0.58 mm, 1.94 ± 0.37 mm, 1.97 ± 0.37 mm and 
1.81 ± 0.61 mm for, Control, BG, PRP and PRP+BG, respectively. The new 
connective tissue adjacent to the root without cementum formation was 0.90 ± 0.28 
mm, 0.84 ± 0.41 mm, 1.07 ± 0.27 mm and 1.15 ± 0.32 mm, respectively. The 
extension of new cementum was 2.63 ± 0.70 mm, 2.56 ± 0.36 mm, 2.37 ± 0.38 mm 
and 3.10 ± 0.47 mm, respectively. The length of new bone was 4.77 ± 0.44 mm, 
4.64 ± 0.68 mm, 4.67 ± 0.46 mm and 4.84 ± 0.42 mm, respectively. The 
percentage of bone filling was 47% on the control group, 50% with BG, 50% with 
PRP+BG and 53% with PRP. At the class II furcation, no statistically significant 
differences were observed in defect extension and new bone (p=0.29).The 
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extension of new cementum was 9.64 ± 1.53 mm and 11.00 ± 1.05 mm (p=0.03) to 
GTR+BG and GTR+BG+PRP, respectively. Within the limits of this study, it can be 
concluded that PRP, BG and their association was not able to increase the amount 
of periodontal regeneration obtained to the treatment of 3-wall intrabony defects in 
dogs. However, it can be assumed that PRP promoted an increase of cementum 
regeneration when applied in association with BG and GTR for the treatment of 
class II furcation lesions in dogs.   
Key Words: periodontal disease/surgery; glass, bioactive; platelet-rich plasma 
(PRP); periodontal regeneration; periodontal defects; intra-bony 
defects; class II furcation. 
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INTRODUÇÃO 
Os objetivos da terapia periodontal incluem a eliminação e controle da 
infecção, e posterior correção anatômica dos defeitos produzidos pela doença, 
através da regeneração do osso alveolar, ligamento periodontal e cemento (Froum 
et al., 2002). Considerando a regeneração periodontal, sabe-se que a mesma 
envolve um processo multifatorial com uma seqüência de eventos biológicos 
incluindo adesão, migração, multiplicação e diferenciação celular (Giannobile, 
1996). 
Apesar da completa regeneração dos tecidos periodontais ainda não ter 
sido alcançada, significantes progressos têm sido realizados através do uso da 
regeneração tecidual guiada (RTG) (Cortellini & Tonetti, 2000), enxertos ósseos 
(Rosen et al., 2000), e mais recentemente fatores de crescimento (Camargo et al., 
2002). Como cada uma das técnicas citadas apresenta aspectos específicos no 
que tange a obtenção da regeneração periodontal, tem sido sugerido que a 
associação de uma ou mais técnicas poderia então melhorar os resultados, 
quando comparadas a qualquer técnica utilizada isoladamente (Camargo et al., 
2002). 
O uso da RTG tem demonstrado resultados favoráveis quanto à 
regeneração periodontal quando aplicados aos defeitos de furca grau II. Vários 
autores têm reportado ganhos significativos para nível clínico de inserção 
horizontal e vertical, além de completo fechamento de furca em até 67% dos 
casos utilizando diferentes tipos de barreiras, como membranas de 
politetrafluoretileno-expandido ePTFE (Blumenthal, 1993), colágeno (Wang et al., 
1994), celulose (Simonpietri et al., 2000) e ácido polilático (Polsson et al., 1995). 
A utilização dos enxertos ósseos vem sendo explorada na regeneração 
periodontal (Nasr et al., 1999), através do uso de diferentes materiais de 
preenchimento, observando-se uma superioridade nos resultados obtidos com os 
enxertos autógenos (Ross & Cohen, 1968; Dragoo & Sulivan, 1973; Hiatt et al., 
1978; Schallhorn & McClain, 1988; Bowers et al., 1989; Park et al., 2001). 
Entretanto, algumas desvantagens vêm sendo vinculadas ao seu uso: segundo 
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sítio cirúrgico, maior tempo cirúrgico, morbidade pós-operatória e quantidade 
limitada de material (Dragoo & Sulivan, 1973; Bowers et al., 1989; Zinner & Small, 
1996; Karring et al., 1997). 
Alternativas para a sua substituição ou associação têm sido avaliadas, 
mostrando resultados promissores com o uso de enxertos aloplásticos. 
Inicialmente introduzido por Hench et al., (1971), o vidro bioativo vem sendo 
estudado na última década apresentando resultados encorajadores no que se 
refere à regeneração periodontal (Wilson & Low, 1992; Fetner et al., 1994) e na 
melhora dos parâmetros clínicos (Low et al., 1997; Zamet et al., 1997; Froum et 
al., 1998; Anderegg et al., 1999; Park et al., 2001). 
O vidro bioativo é um tipo de cerâmica bioativa que consiste de SiO2 (45%), 
CaO (24,5%), Na2O (24,5%) e P2O5 (6%), com tamanho de partícula variando 
entre 90 e 710µ, e formato irregular - Perioglass® (NovaBone Products, LLC - 
USA) (Karatzas et al., 1999). Em contato com os fluídos corpóreos, ele tem a 
capacidade de formar em sua superfície uma camada de hidroxi-carbono-apatita e 
sílica, na qual são incorporadas fibras colágenas, produzindo uma forte adesão 
entre o vidro bioativo e o tecido do hospedeiro, compatível quimicamente e 
estruturalmente com a composição mineral do osso (Karatzas et al., 1999; Low et 
al., 1997). A partir da formação dessas camadas e incorporação de colágeno, 
ocorre a migração de células osteogênicas para a área do defeito por volta de 7 a 
10 dias. Ao mesmo tempo, pode ser verificada a regeneração do cemento e do 
ligamento periodontal na superfície radicular (Greenspan, 1999). 
Dessa forma, o vidro bioativo poderia ser considerado um material 
osteocondutor e osteoindutor (Xynos et al., 2000; Yuan et al., 2001), sendo ainda, 
atribuído ao mesmo uma boa capacidade de hemostasia, tamanho de partículas 
que permita um arranjo adequado para a vascularização, biocompatibilidade, além 
da capacidade de inibir o crescimento epitelial (Wilson et al., 1981; Wilson et al., 
1988; Wilson & Low , 1992; Wilson et al., 1993; Park et al., 2001). 
Apenas a partir do início da década de 90 iniciaram-se os estudos, em 
seres vivos, avaliando histologicamente o efeito do vidro bioativo no reparo 
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periodontal. Sendo que até o atual momento poucos estudos histológicos foram 
desenvolvidos, a fim de esclarecer a real eficácia do uso do vidro bioativo em 
defeitos periodontais (Schepers et al., 1993a,b; Fetner et al., 1994; Karatzas et al., 
1999; Stavropoulos et al., 2003). Apesar de poucos trabalhos histológicos, estudos 
clínicos desenvolvidos a partir da metade da década de 90, avaliando a eficácia do 
vidro bioativo no tratamento de defeitos intra-ósseos, apresentaram sucesso nos 
resultados, quando comparado ao tratamento periodontal convencional (Low et al., 
1997; Zamet et al., 1997; Froum et al., 1998; Ong at al., 1998;  Anderegg et al., 
1999; Nevis et al., 2000;  Park et al., 2001). 
           Mais recentemente, tem-se dado ênfase na utilização do plasma rico em 
plaquetas (PRP) no tratamento de defeitos ósseos periodontais. O gel de PRP é 
derivado de uma preparação autógena de concentrado de plaquetas (Whitman et 
al., 1997), que tem sido aplicado em procedimentos de cirurgia óssea, 
implantodontia e periodontia (Kim et al., 2002; Froum et al., 2002; Grag et al., 
2000). O PRP contém citocinas e fatores de crescimento, entre eles o fator de 
crescimento derivado de plaquetas (PDGF) e o fator de crescimento transformador 
β (TGF-β), os quais auxiliam na maturação acelerada de enxertos ósseos (Christie 
et al., 1997). Tais fatores de crescimento podem regular a atividade dos 
osteoblastos e osteoclastos durante o processo de remodelação óssea, além de 
iniciar e controlar a reparação após um trauma (Lind, 1996). 
           Estudos têm mostrado comprovada eficiência no tratamento de lesões de 
furca (Park et al., 1995), de defeitos ósseos ao redor de implantes de titânio 
quando associado a enxertos ósseos (Whitman & Berry, 1998), e ainda quando 
associados a RTG (Petrungaro, 2002). Quando associados à RTG e enxertos 
ósseos, também foi demonstrado sucesso para o tratamento de defeitos intra-
ósseos e de furca grau II (de Obarrio et al., 2000; Lekovic et al., 2002; Camargo et 
al., 2002). 
           Apesar de resultados clínicos favoráveis ao seu uso associado a outras 
técnicas, apenas um estudo avalia histologicamente sua associação à RTG no 
tratamento de lesões de furca grau III (Park et al., 1995). Até o atual momento não 
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existem estudos controlados, que avaliem histologicamente seu uso associado a 
materiais para preenchimento ósseo para o tratamento de defeitos intra-ósseos e 
nem mesmo sua associação com RTG e substitutos ósseos para o tratamento de 
lesão de furca grau II em cães. 
         Dessa forma se torna de fundamental importância a execução de estudos 
que forneçam dados histológicos que suportem seu uso isoladamente ou 
associado a outras técnicas regenerativas no tratamento de defeitos periodontais. 
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PLATELET-RICH PLASMA AND BIOACTIVE GLASS ON THE TREATMENT OF 
PERIODONTAL INTRA-BONY DEFECTS: A HISTOMETRICAL STUDY IN 
DOGS. 
 
Running title: PRP and bioactive glass in the Treatment of bone defects. 
 
Key findings: The treatment of intra-bony defects was evaluated by using PRP 
and bioactive glass. No significant differences were observed among the 
treatments, even when PRP and bioactive glass were associated.  
 
Authors: 
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ABSTRACT 
Background: Some clinical studies have demonstrated beneficial effects with the 
use of Platelet-rich plasma (PRP) and bioactive glass (BG) on periodontal 
parameters. This study was designed to evaluate, histometrically, the efficacy of 
platelet-rich plasma (PRP) and bioactive glass (BG) on the treatment of periodontal 
intra-bony defects. Methods: Nine mongrel dogs were used in the experiment. 
Three-wall intra-bony defects (4x4x4m) were surgically created at the mesial and 
distal aspect of first mandibular molar and exposed to plaque accumulation for 1 
month. The defects were randomly assigned to: control, BG, PRP, PRP+BG. Dogs 
were sacrificed 90 days after the surgeries and the blocks containing the 
experimental specimens were processed for histological analysis. The histometric 
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parameters evaluated were: length of sulcular and junctional epithelium, 
connective tissue adaptation, new cementum, new bone, percentage of bone filling 
and defect extension. Results: No statistically significant differences were observed 
among the groups in the evaluated parameters. The extension of total epithelium 
(sulcular and junctional epithelium) was 2.24 ± 0.58 mm, 1.94 ± 0.37 mm, 1.97 ± 
0.37 mm and 1.81 ± 0.61 mm for, Control, BG, PRP and PRP+BG, respectively. 
The new connective tissue adjacent to the root without cementum formation was 
0.90 ± 0.28 mm, 0.84 ± 0.41 mm, 1.07 ± 0.27 mm and 1.15 ± 0.32 mm, 
respectively. The extension of new cementum was 2.63 ± 0.70 mm, 2.56 ± 0.36 
mm, 2.37 ± 0.38 mm and 3.10 ± 0.47 mm, respectively. The length of new bone 
was 4.77 ± 0.44 mm, 4.64 ± 0.68 mm, 4.67 ± 0.46 mm and 4.84 ± 0.42 mm, 
respectively. The percentage of bone filling was 47% on the control group, 50% 
with BG, 50% with PRP+BG and 53% with PRP. Conclusion:  Within the limits of 
this study, it was concluded that the use of PRP, BG and their association do not 
promote additional effect to the periodontal regeneration of 3-wall intra-bony 
defects in dogs. 
KEY WORDS: periodontal disease/surgery; glass, bioactive; platelet-rich plasma 
(PRP); periodontal regeneration. 
INTRODUCTION  
The ultimate goal of periodontal therapy includes not only the arrest of 
progressive periodontal disease but also the restitution of those parts of the 
supporting apparatus which have been destroyed by disease.1 Several clinical 
procedures have been used for this purpose so far, such as bone grafts,2-5 
application of growth factors,6-12 or their combination.13,14 
The complex series of events associated with periodontal regeneration 
involves recruitment of locally derived progenitor cells to the site. Therefore, the 
key to periodontal regeneration is to stimulate the progenitor cells to re-occupy the 
defects.15 Growth factors are vital modulators during this process which can induce 
the migration, attachment, proliferation and differentiation of periodontal progenitor 
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cells.16 Platelet-rich plasma (PRP) is derived from concentrated platelets, that 
contain a greater concentration of autologous growth factors including platelet-
derived growth factor (PDGF), transforming growth factor beta (TGF-β), vascular 
endothelial growth factor (VEGF), insulin-like growth factor (IGF-I), and epithelial  
growth factor (EGF) 17-23. Early studies have focused on PRP application to bone 
graft material, showing that it leads to earlier bone regeneration and soft tissue 
healing, as well as greater density of mature trabecular bone 12. Several studies 
using histological techniques suggested that PRP preparations may enhance local 
bone formation 12, 22, 24, while others did not confirm these findings 21, 25, 26, 27. 
 The ability of bioactive glass (BG) particles to promote bone repair has been 
assessed in several experimental models 28-31 BG particles have been shown to 
undergo chemical transformation when they are implanted.32 This process leads to 
the formation of silica gel on the surface of the particles followed by the 
precipitation of amorphous calcium phosphate that in turn crystallizes as hydroxi-
carbonate apatite by incorporating carbonates from the surrounding medium.32 
Hench & Polak (2002)33 have shown that the release of ions (Na, Ca, and Si) from 
BG materials control the cell cycle leading to the differentiation and proliferation of 
bone cells, modulation of the expression of genes that regulate osteogenesis, and 
the synthesis of growth factors. 
Some studies have encouraged the use of PRP to bone and periodontal 
regeneration. Even though, BG seems to be considered a promising alloplastic 
bone graft.  To the author’s knowledge, no histological study evaluating the use of 
PRP, BG and their association for the treatment of intra-bony defects has yet been 
reported in the literature. Therefore, the goal of this investigation is to evaluate, 
histometrically, the healing of surgically created intra-bony defects in dogs treated 
with BG, PRP and PRP+BG.  
 
MATERIAL AND METHODS 
 Nine adult female mongrel dogs were included in the experiment (mean 
weigh = 15 Kg). The study protocol has been approved by the Institutional 
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Committee of Research with Animals. The surgical procedures were performed 
under general anesthesia with intravenous injection of a 3% sodium pentobarbital 
solution (0.5 ml/Kg). The mandibular second and fourth premolars and second 
molars had been extracted previously and the extraction sites had been allowed to 
heal for 2 months. After buccal and lingual mucoperiosteal flaps were elevated and 
4x4x4mm 3-wall intra-bony defects were created at the mesial and distal aspect of 
the left and right mandibular first molar34 (Figure 1). 
 The defects were filled with gutta-percha to prevent spontaneous 
regeneration and exposed to plaque accumulation for a period of one month 
(Figure 2). After this period, scaling and root planing was performed and a regimen 
of daily brushing plus topical application of 0.1% chlorexidine gluconate was 
instituted for 7 days prior to the surgical procedures. 
 
PRP Preparation 
 Blood was obtained 30 minutes before the administration of anesthesia. 
Three tubes (5ml), containing 0.5ml of 3.2% sodium citrate solution as an 
anticoagulant, were drawn from each dog. The tubes were centrifuged at 1,200 
rpm for 10 minutes at room temperature. The blood was thus separated into 3 
basic parts: red blood cells (at the bottom of the tube), platelet enriched plasma (a 
discrete grey line in the middle of the tube) and platelet poor plasma (at the top of 
the tube). The portion corresponding to the platelet poor plasma was discarded 
from each tube and the remaining content was centrifuged again at 1,200 rpm for 
15 minutes. Four hundred µl of the middle portion, corresponding to the platelet 
enriched plasma, were pipetted from each tube. In order to obtain the gel, 30µl of 
10% calcium chloride was added to PRP and heated in a water bath at 37° C. The 
gel was achieved after a period from 10 to 15 minutes 35.  
 
Defect Treatment 
 Mucoperiosteal flaps were carefully reflected on the lingual and buccal 
aspect. The root surface was instrumented with curettes, the apical notch was re-
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established at the base of the defect and the coronal notch at the top of the defect. 
Each defect in each animal (a total of 4 defects / animal) was randomly assigned to 
one of the following treatments (the treatments with PRP were located at the same 
side): 
Control: the defect was naturally filled with coagulum; 
BG (Perioglas): BG particles were applied filling the defect; 
PRP: after obtaining the PRP gel, it was immediately applied on the defect; 
PRP+BG: BG was incorporated to the PRP (1:1) and this assemblage was 
immediately taken to a water bath at 37ºC what enable the formation of a 
mixture of the gel and the BG graft. 
Primary, tension-free wound closure was accomplished following defect 
treatment, with the gingival flaps positioned and sutured with interrupted sutures† at 
their presurgical position. Immediately after the surgeries, an intramuscular 
injection of penicillin (1.5ml – 150,000 IU) was given to the animal. The same 
antibiotic was repeated four days after surgeries. 
Post-operative plaque control was performed by irrigation with a solution of 
1% chlorexidine gluconate (every other day). After 90 days, under general 
anesthesia, the animals were sacrificed with a perfusion of 10% neutral formalin 
solution. The jaws were dissected and the blocks containing the experimental 
specimens were obtained. They were decalcified in a solution of equal parts of 
50% formic acid and 20% sodium citrate for 5 months. The decalcified specimens 
were washed in running water, dehydrated and embedded in paraffin. Bucco--
lingual sections of 7 µm were obtained. They were stained with Hematoxylin and 
eosin. 
Five sections representing the midbuccal portion of each defect were 
selected for the histometric procedures. The sections were blindly presented for 
measurements by one examiner. The following distances were measured: 
 
Total Epithelium (sulcular and junctional epithelium): from the gingival 
margin to the apical border of the junctional epithelium. 
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Connective tissue adaptation (without cementum): from the apical border of 
the junctional epithelium to the coronal end of new cementum. 
New cementum: from the apical notch to the most coronal part of new 
cementum. 
New bone (bone position): from the apical notch to the most coronal extent 
of new bone. Negative values were assigned when the bony crest was 
located apically to the apical notch. 
New bone area: percentage of newly formed alveolar bone to the defect 
area. 
Defect extension: from the apical notch to the coronal notch. 
 
The measurements were performed using a microscope‡ with a 1.25/.035 
objective associated with a video camera§/computer/software║. The extension of 
total epithelium, connective tissue adaptation, new cementum, new bone and 
defect extension were obtained by a linear measurement (x 20). The new bone 
area, were measured through lines intersections that made possible to mark the 
presence or absence of bone (intersection with bone / intersections without bone x 
20). 
 
Statistical analysis 
Mean values for each parameter were obtained per defect. The mean 
values for all groups were determined using the individual means from the 9 dogs. 
After confirming normal distribution (Shapiro-Wilk test), the Friedman test was 
carried out to check the hypothesis of no difference between groups regarding the 
evaluated parameters. The values of P ≤ 0.05 were considered statistically 
significant. 
 
RESULTS 
I - Clinical Observations  
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 Clinically, the healing response was favorable for all treatments. No 
suppuration or abscess formation was observed during the 90 days.  
 
II - Histological Observations 
 No undesirable reactions like inflammation and foreign body reactions were 
observed. All groups presented a similar healing pattern on all the extension of the 
defect, characterized by the presence of a great amount of new cementum 
(approximately 50% of the defects), new bone up to the top of the defect, a small 
amount of connective tissue and epithelium (Figure 3). On the defects treated with 
BG, it was observed the presence of a considerable amount of graft particles 
remaining. Some defects presented bone in contact and surrounding the BG 
particles (Figure 4). However this was not a common finding. Almost all defects 
presented a very dense connective tissue surrounding the remaining particles with 
some areas suggesting the formation of new bone. Root resorption and ankylosis 
was not observed. Connective tissue with collagen fibers running parallel to the 
root surface was also observed in these areas and on the surfaces that do not 
presented new cementum but presented new bone. 
 
III – Histometric Measurements 
 The histometric results are shown in Table 1. No statistically significant 
difference was found among all groups in all parameters. 
   
DISCUSSION 
 The use of different regenerative approaches in the treatment of periodontal 
defects has demonstrated a limited clinical result. Some techniques have been 
used in association, aiming to increase their effect on periodontal regeneration. 
This study compares the use of bioactive glass (BG), platelet-rich plasma (PRP) 
and their association on the treatment of intra-bony defects in dogs. 
  The need for an alternative to autologous and allogenic bone grafts have 
encouraged researches to develop a material that could be safe, surgically 
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convenient, offer pecuniary benefits, and predictably promote regeneration with a 
reduced morbidity. Recently, BG has been used to bone and periodontal 
regeneration based on its osteoconductive properties. Clinical reports have 
demonstrated favorable results after the use of BG in terms of reducing probing 
depth and improving clinical attachment levels 36-42,. In addition, BG have 
demonstrated a similar clinical response to demineralized freeze-dried bone 
(DFDBA) on the treatment of intra-bony defects 43.  
In spite of the benefits showed by clinical studies using BG, histological 
results of human and animal studies have demonstrated a limited effect on bone 
and periodontal regeneration.  Schimit et al (1997)44, compared a porous bone 
mineral with biologically active glass and observed a small amount of new bone 
after the use of active glass. They observed a reduction on the amount of bioactive 
glass between 4 and 8 weeks without any sign of osteoclast response. The authors 
suggested that other cell phenotype or solution-mediated processes were 
responsible for the reduction. Add to this fact, it was observed a more robust 
fibrous response on defects treated with bioactive glass. In the present study the 
histological evaluation was carried out at the end of 90 days. At this time, the 
groups treated with BG, demonstrated residual material frequently surrounded by a 
dense connective tissue. However it was noted in some defects, the presence of 
BG particles in direct contact to bone and areas suggesting the presence of a non 
mature bone. 
 Histological observations after treatment of periodontal defects with BG in 
nonhuman primates showed a significant increase of new cementum and inhibition 
of downgrowth of junctional epithelium in comparison with open flap debridement 
45. The authors supported part of these findings on the nonhuman primate model, 
justifying being a better situation to observe the real effect of BG in comparison to 
open flap debridement. 
In the present study, the 3-wall intra-bony defects were filled with gutta-
percha and submitted to plaque accumulation for a period of one month. The 
results of the control group are in accordance with the previous report that 
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demonstrated a high potential of regeneration of these defects, with the formation 
of almost 75% of new cementum22. In the present study the observed new 
cementum formation was approximately 57% in the control group. It can be 
hypothesized that the smaller value observed for this parameter when compared to 
the literature might have been a consequence of the plaque accumulation period 
included in the protocol.  The 3-wall intra-bony defect has been used in animal 
studies probably because this type of defect is a common indication for 
regenerative techniques in a clinical set 22, 34, 46. According to Kim et al (2004)22, 
healing of intrabony defects appears to be dependent on the number of bone walls 
of the defect. Increasing the number of walls would increase the potential for 
regeneration as a consequence of wound stability and uneventful maturation of the 
tooth-gingival flap interface. The 3-wall intrabony defect can be considered a 
reproducible model to evaluate different regenerative procedures and a preclinical 
model that are relatively easy to manage and from which homogeneous healing 
outcomes may be expected 22. Considering these defect characteristics (contained 
defect with an ideal condition for coagulum stability), the good response of the 
control group was an expected finding and it represented a great challenge for the 
tested materials.  
When using BG to promote bone regeneration 47, 48, it could be possible to 
achieve an osteoconductive effect improving bone filling and providing direct 
contact of the bone to the particles of the graft. The present study corroborated 
with the hypothesis of BG acting as osteoconductive graft, demonstrating new 
bone formation on periodontal bone defects and direct contact of new bone with 
BG particles in some defects. 
Histological evaluation of BG on the treatment of intra-bony defects in 
humans showed a significant apical proliferation of epithelium in most of the 
sections to a subosseous level, approaching the limit of the original defect. It was 
observed only a limited amount of new cementum and connective tissue 
attachment at the most apical portion of the defects, excepting one of the cases 
that presented new cementum and connective tissue formation 49. However, a 
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recent histological study 50, evaluating the use of BG on the treatment of 2-wall 
intra-bony defects in monkeys, suggested that this graft can exert an 
osteostimulatory effect. This was demonstrated by the new bone formation on the 
particles located distant from the defect wall. Also, the authors reported an 
inhibitory effect on the apical migration of the epithelium. In the present study, it 
was not observed an extensive apical migration of the epithelium and it was 
demonstrated the presence of new cementum and bone regeneration, even on the 
coronal areas of the defect. 
It is known that periodontal ligament cells exhibit phenotypic characteristics 
consistent with ostoblast-like cells and have the potential to differentiate into 
osteoblasts and/or cementoblasts 51. The polypeptide growth factors (PGFs) have 
been applied to promote periodontal regeneration.  PGFs, are molecules that have 
been identified in the periodontal tissues and that are implicated in the growth and 
differentiation of cells from these tissues 52, 53. PRP is a novel approach to obtain 
autologous PGFs, specifically platelet growth factor (PDGF) and transforming 
growth factor β (TGFβ). PRP stimulates PDL cells and fibroblastic cell proliferation 
in vitro 54, 55. Consequently, by ordering these cellular responses into a series of 
related events, PRP may efficiently facilitate wound-healing and tissue 
regeneration. In addition, PRP suppressed epithelial cell division in vitro 56. Its 
ability to suppress epithelial cell proliferation seems advantageous for periodontal 
regeneration by favoring the formation of a new connective tissue attachment on 
the root surface. The results of the present study do not suggest that the use of 
PRP can promote an additional effect in terms of periodontal regeneration of 3 wall 
intra-bony defects. There are only a few studies comparing the clinical and 
histological effects of PRP/graft with graft material alone. Hanna et al (2004) 57, 
demonstrated that the association of PRP and bovine-derived xenografts produced 
a greater reduction of pocket depth and gain on clinical attachment level, both 
statistically significant. That corroborate with the findings reported to Okuda et al. 
(2005) 58, when PRP was associated with hydroxyapatite for the treatment of intra-
bony defects. In spite of these clinical results, other clinical studies failed to 
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demonstrate additional effect of PRP on periodontal and bone regeneration 1, 59-63. 
In a 3-wall peri-implant defects in dogs, treated with PRP associated to xenogenic 
bone graft, PRP demonstrated a low bone regenerative potential 63. The same 
authors also reported no significant effect with the addition of PRP to xenogenic 
bone grafts on bone mineral density or graft maturity 65. These observations 
corroborate with the results of the present study, which do not demonstrate any 
additional effect of PRP on periodontal and bone regeneration of 3 wall intra-bony 
defects.  
 The ideal platelet and growth factors concentration to promote periodontal 
regeneration has not been established. To the date, there is insufficient information 
about growth factor interactions and how they influence the activations of gene 
expression and protein production. In the present study, the achieved percentage 
mean of platelet concentration was 227.02 % (mean of 463,015 platelets/µL) in 
relation to blood platelets count. Lacoste et al.(2003) 66 reported that growth factors 
may act at specific times and at appropriate concentrations and this may be other 
explanation for the different results in studies with PRP. 
The technique to produce PRP in the present study was introduced by Jahn 
(2002) 67 and was used in other animal studies by our group, Casati et al.(2007) 35. 
This technique enables to produce a platelet concentration generally four times 
greater than the whole blood. As the use of thrombin in this kind of study is not 
allowed in our country. Instead of thrombin, 10% calcium chloride was added to 
PRP and heated in a water bath at 37° C in the present study. Lacoste et al. 66 
performed a study that measured the concentrations of bFGF, VEGF, PDGF-BB 
and TGF-β1 released from platelet concentrate and whole blood, before and after 
the addition of calcium alone, thrombin alone and various concentrations of 
calcium and thrombin. They observed that calcium chloride, regardless of the use 
of thrombin, released platelet growth factors. In this study, the concentration of 
growth factors that was released was sufficient to promote endothelial cell 
proliferation in vitro 66. 
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One of the limitations of this study is that data collected from animal 
models may not be directly applied to human populations due to species specific 
differences such as healing rates and disease activity. 
Within the limits of this animal study, it was concluded that PRP, BG and 
their combination do not exert additional effect to periodontal regeneration in 3-wall 
intra-bony defects in dogs. More studies are necessary to investigate the 
advantages and limitations of these grafts in the treatment of periodontal defects.  
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Table 1- Mean and Standard Deviation (SD) for the parameters evaluated to all 
treatments (Control, BG, PRP and PRP + BG). 
 
Mean ± SD 
Parameters 
 
Control 
 
BG 
 
PRP 
 
PRP + BG 
 
p† 
Total epithelium 2.31 ± 0.74 1.97 ± 0.53 2.12 ± 0,44 2.13 ± 0.67 0.45 
Connective tissue 0.93 ± 1.22 0.83 ± 0.69 1.07 ± 1.37 1.54 ± 1.29 0.59 
New cementum 3.18 ± 1.28 3.32 ± 1.08 3.41 ± 1.10 3.41 ± 1.10 0.85 
New bone 4.72 ± 0.50 4.59 ± 0.58 4.33 ± 0,28 4.33 ± 0.28 0.85 
New bone area 0.47 ± 0.09 0.50 ± 0.20 0.53 ± 0,05 0.50 ± 0.11 0.63 
Defect extension 4.42 ± 0.14 4.45 ± 0.41 4.40 ± 0.27 4.40 ± 0.27 0.74 
* Values in millimeters, except to New bone area (%). 
† Shapiro- Wilk test (p > 0.05) 
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Figure 1- Clinical view of surgically created 3-wall intrabony defect (4x4x4mm) at 
the mesial aspect of first mandibular molar. 
 
 
Figure- Clinical view of the insertion of gutta-percha and the disposable to promote 
plaque accumulation for one month. 
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Figure 3- Photomicrograph of a 3-wall intrabony defect showing new bone and 
cementum formation above apical notch (H&E, original magnification x20). A) 
Control; B) PRP; C) BG; D) PRP+BG. New cementum could be observed until the 
middle of the defect and new bone near to the coronal notch, demonstrating 
histological defect filling with periodontal regeneration (A, B, C and D). Particles of 
BG could be observed surrounded by new bone and connective tissue (C and D). 
Arrows indicated areas with new bone in contact with BG particles. 
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FIGURE 4- New bone formation observed on 3-wall intrabony defect (H&E, original 
magnification x100). Arrows indicate direct bone in contact with BG. 
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ABSTRACT 
Background: Some clinical studies have demonstrated a successful use of Platelet-
rich plasma (PRP) in association with GTR and bone graft on periodontal 
regeneration of intra bony defects and class II furcation lesions. The purpose of 
this study was to evaluate, histometrically, the effect of platelet-rich plasma (PRP) 
on the treatment of class II furcation lesions. 
Methods: Nine mongrel dogs were used in the experiment. Class II furcation 
lesions (5x2mm) were surgically created, bilaterally, at the buccal aspect of 
mandibular third premolar and exposed to plaque accumulation for 1 month. The 
defects were randomly assigned to: GTR+BG and GTR+BG+PRP. Dogs were 
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sacrificed 90 days after the surgeries and the blocks containing the experimental 
specimens were processed for histological analysis. The histometric parameters 
evaluated were: length of new cementum, new bone and defect extension.  
Results: No statistically significant differences were observed in defect extension 
and new bone (p=0.29).The extension of new cementum was 9.64 ± 1.53 mm and 
11.00 ± 1.05 mm for GTR+BG and GTR+BG+PRP, respectively (p=0.03) 
Conclusion: Within the limits of this study, it was concluded that the use of PRP in 
association with GTR and BG enhance the amount of new cementum when 
applied to the treatment of class II furcation lesions in dogs. 
 
KEY WORDS: periodontal disease/surgery; guided tissue regeneration; GTR; 
glass, bioactive; platelet-rich plasma (PRP); periodontal regeneration. 
 
 
INTRODUCTION  
Teeth with furcation involvement undergo more extensive and rapid clinical 
probing attachment loss and are lost with greater frequency than single-rooted 
teeth 1, 2, 3. Although regeneration of periodontal tissue is the ultimate goal of 
periodontal therapy, regeneration is not a predictable healing outcome after 
conventional treatment 4. 
With the advent of regenerative techniques, a new concept of periodontal 
treatment based on the principle of cellular selection5 and guided tissue 
regeneration 6, permits the treatment of teeth with furcation lesions by more 
conservative surgical methods. Various studies reported gains in horizontal and 
vertical clinical attachment, with complete closure of the furcation in up to 67% of 
the cases using different types of mechanical barriers 7, 8, 9, 10. Despite of the very 
promising results based on reports of substantial attachment gain and bone fill of 
furcations, GTR is technique sensitive and could be associated with increased 
postoperative problems. A major drawback to ePTFE and other non-resorbable 
membranes is the need for their removal after 4 to 6 weeks, often with a surgical 
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procedure, that adds to patient morbidity and may disturb the young healing 
regenerative tissue 11. 
Bone replacement graft have achieved similar results to GTR, 
demonstrating a 55% overall improvement either complete or partial furcation fill 
compared to 52% for GTR 12. The use of bioactive glass (BG) compared to an 
ePTFE barrier may produce equal clinical results 11. When used in a variety of 
periodontal and oral surgical applications, BG has shown good clinical and 
histological profiles 13, 14, 15, 16. 
In the past decade, several cytokines, or growth factors, have received 
attention because they can regulate migration, attachment, proliferation and/or 
differentiation of periodontal ligament cells into hard tissue cells and have been 
shown to enhance regeneration in vivo experiments 17, 18, 19, 20. Recently, there has 
been an increasing interest in the potential applications of polypeptide growth 
factors (PGFs), influence by the fact that of all PGFs know, platelet-derived growth 
factor (PDGF) has shown to exert a favorable effect on periodontal regeneration as 
measured by gain in clinical attachment and defect fill in humans 21. A convenient 
technique to obtain a high concentration of the PGFs like transforming growth 
factor β (TGFβ) and PDGF is by preparing autologous platelet-rich plasma (PRP)22. 
Considering that the most favorable outcome of periodontal regenerative 
procedures in furcations lesions has been achieved with a combination of graft 
material and guided tissue regeneration (GTR) 13, 23, 24, 25, 26, the goal of the present 
study is to investigate the histological effect of PRP associated with GTR 
(resorbable barrier) and bioactive glass (bone graft) on the regeneration of class II 
furcation lesions created in dogs.  
 
MATERIAL AND METHODS 
 Nine adult female mongrel dogs were included in the experiment (mean 
weigh = 15 Kg). The study protocol has been approved by the Institutional 
Committee of Research with Animals. The surgical procedures were performed 
under general anesthesia with intravenous injection of a 3% sodium pentobarbital 
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solution (0.5 ml/Kg). The mandibular second and fourth premolars had been 
bilaterally extracted previously and the extraction sites had been allowed to heal for 
2 months. In order to create the defects a buccal mucoperiosteal flap was raised to 
expose the alveolar buccal bone. Experimental class II furcations were created in 
the third premolar. Osteotomy was done in the furcation area with high-speed 
diamond burs with constant irrigation and with Nos. 1 and 2 Ochsenbein chisels 
(Hu-Friedy). The furcations lesions were standardized with a millimeter probe and 
measured approximately 5.0mm in the apico-occlusal direction and 2.0mm in the 
bucco-lingual direction (Figure 1), following a technique previously described 27. 
 The defects were filled with gutta-percha to induce an inflammatory 
response due to plaque accumulation for a period of one month (Figure 2). After 
this period, scaling and root planing was performed and a regimen of daily 
brushing plus topical application of 0.1% chlorexidine gluconate was instituted for 7 
days prior to the surgical procedures. 
 
PRP Preparation 
 Blood was obtained several minutes before the administration of anesthesia. 
Three tubes (5ml), containing 0.5ml of 3.2% sodium citrate solution as an 
anticoagulant, were drawn from each dog. The tubes were centrifuged at 1,200 
rpm for 10 minutes at room temperature. The blood was thus separated into 3 
basic parts: red blood cells (at the bottom of the tube), platelet enriched plasma (a 
discrete grey line in the middle of the tube) and platelet poor plasma (at the top of 
the tube). The portion corresponding to the platelet poor plasma was discarded 
from each tube and the remaining content was centrifuged again at 1,200 rpm for 
15 minutes. Four hundred µl of the middle portion, corresponding to the platelet 
enriched plasma, were pipetted from each tube. In order to obtain the gel, 30µl of 
10% calcium chloride was added to PRP and heated in a water bath at 37° C. The 
gel was achieved after a period from 10 to 15 minutes 28.  
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Defect Treatment 
 Mucoperiosteal flaps were carefully reflected on the buccal aspect of the 
experimental sites, bilaterally, to perform reconstructive surgery. The granulation 
tissue was removed by curettage, and the exposed root surface was instrumented. 
On the root surface, the base of the defect was marked with curettes to establish a 
landmark for the histomorphometric analysis. Each defect in each animal (a total of 
2 defects / animal) was randomly assigned to one of the following treatments: 
GTR + BG (Perioglas): BG particles were applied filling the defect and 
absorbable membrane (Gore-Tex, WL Gore) was adapted to the defect; 
GTR + BG + PRP: BG was incorporated to the PRP (1:1) and this 
assemblage was immediately taken to a water bath at 37ºC what enable the 
formation of a mixture of the gel and the BG graft. This mixture was applied 
filling the defect and absorbable membrane was adapted to the defect. 
Primary, tension-free wound closure was accomplished following defect 
treatment, with the gingival flaps positioned and sutured with interrupted sutures† at 
their presurgical position. Immediately after the surgeries, an intramuscular 
injection of penicillin (1.5ml – 150,000 IU) was given to the animal. The same 
antibiotic was repeated four days after surgeries. 
Post-operative plaque control was performed by irrigation with a solution of 
1% chlorexidine gluconate (every other day). After 90 days, under general 
anesthesia, the animals were sacrificed with a perfusion of 10% neutral formalin 
solution. The jaws were dissected and the blocks containing the experimental 
specimens were obtained. They were decalcified in a solution of equal parts of 
50% formic acid and 20% sodium citrate for 5 months. The decalcified specimens 
were washed in running water, dehydrated and embedded in paraffin. Bucco-
lingual sections of 7 µm were obtained. They were stained with Hematoxylin and 
eosin. 
Five sections representing the midbuccal portion of each defect were 
selected for the histometric procedures. The sections were blindly presented for 
measurements by one examiner. The following distances were measured: 
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New cementum: extension of cementum on the root surface limited by the 
notch on the mesial and distal aspect of the defect. 
New bone: extension of bone from the apical limit (determined by the notch) 
of the defect to the most coronal extent of new bone. 
Defect extension: extension from the apical limit of the defect (determined 
by the notch) to the furcation fornix. 
 
The measurements were performed using a microscope‡ with a 1.25/.035 
objective associated with a video camera§/computer/software║. The extension of 
total epithelium, connective tissue adaptation, new cementum, new bone and 
defect extension were obtained by a linear measurement. 
 
Statistical analysis 
Mean values for each parameter were obtained per defect. The mean 
values for all groups were determined using the individual means from the 9 dogs. 
After confirming normal distribution, the pared t-test was carried out to check the 
hypothesis of no difference between groups regarding the evaluated parameters. 
The values of P ≤ 0.05 were considered statistically significant. 
 
RESULTS 
I - Clinical Observations  
 Clinically, the healing response was favorable for all treatments. No 
suppuration or abscess formation was observed during the 90 days and no 
exposure of membranes was observed in both groups during the healing period. 
 
II - Histological Observations 
 There were no instances of epithelial downgrowth, ankylosis or root 
resorption observed in all sites. No inflammation and foreign body reactions 
indicating toxicity were observed. A similar healing pattern was observed in both 
groups regarding defect filling, remaining graft particles, formation of new 
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cementum and new bone (Figure 3). The defect filling was achieved with both 
treatments in all sites. All defects presented variables amounts of BG remaining 
particles with different sizes. Various defects in both groups presented bone 
surrounding BG particles and bone in direct contact with these graft particles. 
Some small areas of the defects presented a very dense connective tissue 
surrounding the remaining particles. Connective tissue with collagen fibers running 
parallel to the root surface was also observed in these areas and on the root 
surface adjacent to areas that presented new bone formation (Figure 4). 
 
III – Histometric Measurements 
 The histometric results are shown in Table 1. Statistically significant 
difference was observed between treatments in the cementum extension (p=0.03). 
   
 
DISCUSSION 
In this study, it was evaluated if local application of platelet-rich plasma 
(PRP) on class II furcation lesions would enhance periodontal regeneration when 
associated with guided tissue regeneration (GTR) and bioactive glass (BG). 
Previous clinical report, applying GTR, bone graft and PRP demonstrated 
effectiveness of this therapy on periodontal regeneration of class II furcations 22. 
Also other clinical reports, evaluating the same association on the treatment of 
intrabony defects demonstrated similar results 29, 30, 31. 
This is the first report on the use of an association of GTR/BG/PRP in the 
treatment of furcation lesions in dogs. The present study corroborates with 
previous clinical studies 22, 29, 30, 31, demonstrating a positive result with the use of 
this combination of therapeutic modalities for periodontal regeneration. It was 
observed a great amount of periodontal regeneration in almost all defects of both 
treatments.  After the treatment with PRP the amount of new cementum was 
significantly greater than in the group without PRP (p=0.03). The use of different 
regenerative approaches in the treatment of periodontal defects has demonstrated 
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a limited result in terms of regeneration. Therefore, combined approaches has 
been suggested 13, 23, 25, 26, aiming to increase the amount of periodontal 
regeneration. This possibility was confirmed in the present study with the group 
RTG+BG+PRP for the treatment of class II furcation lesions in dogs. 
It has been demonstrated that when a bone graft or substitute is combined 
with the GTR procedure in furcation lesions, a greater amount of defect fill is 
observed 13, 23, 25, 26. This advantage can be explained by the osteoconductive 
and/or osteoinductive properties of the graft materials. One of the promising bone 
substitutes that have been investigated is the bioactive glass (BG), a safe and 
surgical convenient material that has been suggested as an osteoconductive graft 
32, 33, 34. An osteostimulatory effect has also been suggested to this material by 
some researchers, which demonstrated this effect at histological level 35 when 
applied the material for the treatment of 2-wall intra-bony defects in monkeys. The 
authors reported an inhibitory property on the apical migration of the epithelium 
and new bone formation on the particles located distant from the defect walls. This 
healing pattern was not observed in open flap debridement group. 
The sites treated with GRT+BG showed new cementum and new bone 
regeneration with defect filling. These results are in accordance with previous 
reports, which demonstrated beneficial effects with the association of GTR and 
bone substitutes 13, 23, 25, 26. Clinical studies do not provide information about the 
nature of the healing process after these procedures. Therefore, histological 
evaluation of periodontal defects is the only reliable method  to determine the 
healing response of the periodontal soft and hard tissue on sites treated with GTR 
and/or bone substitutes. 
Evidence supporting the use of PRP has been based on the idea that this 
preparation contains polypeptide growth factors (PGFs). These are molecules that 
have been identified in the periodontal tissues and have been implicated in the 
growth and differentiation of cells from periodontal tissues 36, 37. Some specific 
PGFs, like PDGF and TGFβ, could promote the growth and differentiation of the 
periodontal ligament and alveolar bone cells and could be responsible for the 
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clinical improvement observed in experimental sites.  PRP is a method to obtain 
autologous PGFs, specifically PDGF and TGFβ. In vitro studies suggested that 
members of the TGFβ superfamily and PDGF act as proliferation and 
differentiation agents on a preosteoblastic cell line 38. In vitro studies also 
demonstrated that PRP stimulates PDL cells and fibroblastic cell proliferation 39, 40. 
Other interesting feature of PRP is its sticky consistency due to its high fibrin 
content. The fibrin component of PRP may work as a hemostatic agent aiding in 
stabilizing the graft material and the blood clot 41, 42. The fibrin component of PRP 
may also adhere to the root surface impeding migration of cells from the flap 43. 
No histological studies have evaluated the use of PRP in association with 
GTR and bone grafts. To our knowledge, this is the first study that evaluated, in the 
histological level, the effect of the association of GTR, BG and PRP on periodontal 
regeneration of class II furcation lesions in dogs. Clinical reports have already 
demonstrated that the association of GTR, bone substitutes and PRP could be an 
effective modality of periodontal regenerative therapy for intrabony defects and 
class II furcation lesions as reveled by gain in clinical attachment, defect fill at 
reentry, reducing probing depth, vertical defect fill and horizontal defect fill 22, 29, 30, 
31. 
Clinical and histological studies comparing the effects of PRP/graft with graft 
material have been previously reported. Hanna et al (2004)44, demonstrated that 
the association of PRP and bovine-derived xenografts produce a greater reduction 
on pocket depth and gain on clinical attachment level, both statistically significant. 
That corroborate with the findings reported to Okuda et al. (2005)45, when PRP 
was associated with hydroxyapatite for the treatment of intra-bony defects. In spite 
of these clinical results, other clinical studies failed to demonstrate additional effect 
of PRP on periodontal and bone regeneration 46-51. In 3-wall peri-implant defects in 
dogs treated with PRP associated to xenogenic bone graft, a low bone 
regenerative potential was observed 52. The same authors also reported no 
significant effect with the addition of PRP to xenogenic bone grafts on bone mineral 
density or graft maturity 53, 54. The present results demonstrated that PRP 
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promoted additional effect to periodontal regeneration, increasing the amount of 
new cementum when associated with GTR and BG. However, no additional effect 
was observed for new bone formation when compared to GTR+BG. 
 To the date, there is insufficient information about growth factor interactions 
and how they influence the activations of gene expression and protein production. 
Also, the ideal platelet and growth factors concentration to promote periodontal 
regeneration has not been established. Lacoste et al.(2003)55 reported that growth 
factors may act at specific times and at appropriate concentrations and this may be 
other explanation for the different results in studies with PRP. In the present study, 
the achieved percentage mean of platelet concentration was 227.02 % (mean of 
463,015 platelets/µL) in relation to blood platelets count.  
The technique to produce PRP in the present study was introduced by Jahn 
(2002)56 and was used in other animal studies by our group, Casati et al. (2007)38. 
This technique enables to produce a platelet concentration generally four times 
greater than the whole blood. Lacoste et al. 55 performed a study that measured 
the concentrations of bFGF, VEGF, PDGF-BB and TGF-β1 released from platelet 
concentrate and whole blood, before and after the addition of calcium alone, 
thrombin alone and various concentrations of calcium and thrombin. They 
observed that calcium chloride, regardless of the use of thrombin, released platelet 
growth factors. In this study, the concentration of growth factors that was released 
was sufficient to promote endothelial cell proliferation in vitro55. As the use of 
thrombin in this kind of study is not allowed in our country, instead of thrombin, 
10% calcium chloride was added to PRP and heated in a water bath at 37° C in the 
present study. 
Future studies are required to clarify the mechanism of action of PRP in the 
periodontal regeneration process and the ideal platelet and growth factors 
concentration to adequately promote periodontal regeneration. Within the limits of 
this animal study, it was concluded that PRP in association with GTR and BG 
enhance the amount of new cementum when applied to the treatment of class II 
furcation lesions in dogs.  
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Table 1- Mean and Standard Deviation (SD) for the parameters evaluated to both 
treatments (RTG+BG and RTG+BG+PRP). 
 
Mean ± SD 
Parameters 
 
RTG+BG 
 
RTG+BG+PRP 
 
p† 
Defect high 5.07 ± 0.60 5.11 ± 0.58 0.29 
Defect extension 11.38 ± 0.96 11.45 ± 1.15 0.32 
New cementum 
extension 
9.17 ± 2.02 11.07 ± 1.19 0.01 
New bone (high) 3.94 ± 0.96 4.46 ± 0.59 0.31 
Connective extension 2.33 ± 0.96 - 0.02 
Epithelial extension 3.24 ± 0.71 - 0.08 
* Values in millimeters; † paried-test (p > 0.05) 
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Figure 1- Clinical aspect of Class II furcation defect (5x2mm). 
 
Figure 2- Clinical aspect of Class II furcation defect filled with gutta-percha. 
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Figure 3- Mesiodistal histologic section of Class II furcation lesion 12 weeks after 
treatment defect (H&E, original magnification x20): A) BG+GTR and B) 
PRP+BG+GTR. Both treatments promote defect fill, demonstrating cementum and 
bone regeneration. Above to the notch (N), new cementum of reduced thickness 
was observed. Remaining BG particles were observed surrounded by bone, 
connective tissue and some areas suggest the presence of a newly formed bone 
adjacent to BG particles. 
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Figure 4- A) Photomicrograph of a Mesiodistal histologic section of Class II 
furcation lesion (PRP+BG+GTR) 12 weeks after treatment defect (Masson 
trichrome stain, original magnification x40). New cementum (NC) was observed 
above the notch (N). Remaining BG particles were observed surrounded by new 
bone (NB), connective tissue (CT) and areas suggesting the presence of immature 
bone (IB) in contact with BG; B) Histologic section of the PRP+BG+GTR defect, 12 
weeks after treatment (H&E, original magnification x100). Remaining BG particles 
could be observed surrounded by NB and CT. Some areas indicated the new bone 
formation occurring around BG particles (arrows). 
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CONCLUSÃO 
Dento dos limites deste estudo pode-se concluir que o uso do VB e PRP de forma 
isolada ou associada não promoveram efeito adicional à regeneração periodontal 
em defeitos intra-ósseos de três paredes em cães. Entretanto, pode-se concluir 
também que o uso do PRP promoveu uma maior formação de cemento em 
defeitos de furca grau II em cães, quando associado ao VB e à RTG.  
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